Status:

NOT_YET_RECRUITING

Intravenous Acetaminophen to Reduce Post-operative Opioid Consumption

Lead Sponsor:

Centre hospitalier de l'Université de Montréal (CHUM)

Conditions:

Post Operative Analgesia

Opioid Consumption, Postoperative

Eligibility:

All Genders

18+ years

Phase:

PHASE4

Brief Summary

Acetaminophen (Tylenol) is a commonly used medication after surgery to control pain. Tablets for oral use and suppositories for rectal use are the most frequently employed forms of acetaminophen after...

Detailed Description

In 2019, the Institut national d'excellence en santé et services sociaux (INESSS) stated that IV acetaminophen is an acceptable short-term pain treatment option in combination with opioid analgesics f...

Eligibility Criteria

Inclusion

  • Age 18 years or older.
  • Underwent abdominal surgery
  • Underwent elective surgery.
  • Hospitalized in the digestive surgery, hepatobiliary and pancreatic surgery, or gynecology and gynecologic oncology units at CHUM.
  • Declared NPO immediately post-surgery, meaning they cannot take oral medications.

Exclusion

  • Hypersensitivity to acetaminophen or an excipient in the administered formulations
  • Hepatic insufficiency with a Child-Turcotte-Pugh score of B or C.
  • Weight \< 50 kg (patients requiring a lower acetaminophen dose).
  • Active pregnancy or breastfeeding.
  • Opioid use disorder (OUD) under active treatment
  • Non-opioid-naïve patients: those who received a long-acting opioid within seven days preceding surgery. This criterion will be verified through patient interviews and cross-checked with medical records.
  • Use of illicit recreational substances.
  • Prior participation in this study.
  • Ectopic patients: physically located in a unit other than digestive surgery (11 South), hepatobiliary and pancreatic surgery (14 South), or gynecology and gynecologic oncology (12 South).

Key Trial Info

Start Date :

April 28 2025

Trial Type :

INTERVENTIONAL

Allocation :

ESTIMATED

End Date :

August 15 2025

Estimated Enrollment :

140 Patients enrolled

Trial Details

Trial ID

NCT06923540

Start Date

April 28 2025

End Date

August 15 2025

Last Update

April 11 2025

Active Locations (1)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (1 locations)

1

Centre Hospitalier de l'Université de Montréal

Montreal, Quebec, Canada, H2X 0A9